Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.440
-0.010 (-0.69%)
Jun 1, 2026, 4:00 PM EDT - Market closed
Boundless Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 17.48 | 17.87 | 26.59 | 23.71 | 10.95 | 34.29 |
Short-Term Investments | 75.36 | 89.71 | 125.53 | 97.05 | 55.77 | 38.74 |
Cash & Short-Term Investments | 92.85 | 107.58 | 152.11 | 120.75 | 66.72 | 73.03 |
Cash Growth | -32.84% | -29.28% | 25.97% | 80.99% | -8.65% | - |
Other Current Assets | 1.77 | 2.03 | 2.28 | 3.45 | 1.32 | 1.54 |
Total Current Assets | 94.62 | 109.61 | 154.39 | 124.2 | 68.04 | 74.57 |
Net Property, Plant & Equipment | 45.77 | 46.88 | 51.36 | 4.58 | 7.73 | 3.1 |
Long-Term Investments | - | - | - | - | - | 34.99 |
Other Long-Term Assets | 0.58 | 0.57 | 0.66 | 1.12 | 1.07 | 1.07 |
Total Assets | 140.97 | 157.06 | 206.41 | 129.89 | 76.83 | 113.72 |
Accounts Payable | 5.71 | 6.73 | 5.35 | 4.27 | 2.84 | 1.98 |
Accrued Expenses | 0.59 | 2.64 | 2.78 | 2.9 | 2.46 | 1.31 |
Current Portion of Leases | 3.28 | 3.17 | - | 2.2 | 2.34 | 0.38 |
Other Current Liabilities | - | - | - | - | 0.09 | 0.21 |
Total Current Liabilities | 9.58 | 12.54 | 8.14 | 9.36 | 7.73 | 3.87 |
Long-Term Leases | 45 | 45.87 | 47.63 | - | 2.85 | - |
Other Long-Term Liabilities | - | - | - | - | 0.01 | 0.1 |
Total Long-Term Liabilities | 45 | 45.87 | 47.63 | - | 2.85 | 0.1 |
Total Liabilities | 54.59 | 58.41 | 55.77 | 9.36 | 10.58 | 3.96 |
Common Stock | 0 | 0 | 0 | - | - | 0 |
Additional Paid-in Capital | 359.63 | 358.26 | 351.99 | 8.99 | 5.38 | 2.76 |
Accumulated Other Comprehensive Income | -0.02 | 0.06 | 0.12 | 0.04 | -0.4 | -0.18 |
Retained Earnings | -273.22 | -259.67 | -201.47 | -136.11 | -86.68 | -40.77 |
Total Common Shareholders' Equity | 86.38 | 98.65 | 150.64 | -127.08 | -81.7 | -38.19 |
Minority Interest | - | - | - | 247.62 | 147.95 | 147.95 |
Shareholders' Equity | 86.38 | 98.65 | 150.64 | 120.54 | 66.25 | 109.76 |
Total Liabilities & Equity | 140.97 | 157.06 | 206.41 | 129.89 | 76.83 | 113.72 |
Total Debt | 48.29 | 49.04 | 47.63 | 2.2 | 5.18 | 0.38 |
Net Cash (Debt) | 44.56 | 58.55 | 104.48 | 118.56 | 61.53 | 72.66 |
Net Cash Growth | -23.89% | -43.96% | -11.87% | 92.67% | -15.31% | - |
Net Cash Per Share | 1.99 | 2.62 | 6.15 | 97.50 | 56.04 | 84.43 |
Book Value | 86.38 | 98.65 | 150.64 | -127.08 | -81.7 | -38.19 |
Book Value Per Share | 3.86 | 4.41 | 8.87 | -104.51 | -74.40 | -44.38 |
Tangible Book Value | 86.38 | 98.65 | 150.64 | -127.08 | -81.7 | -38.19 |
Tangible Book Value Per Share | 3.86 | 4.41 | 8.87 | -104.51 | -74.40 | -44.38 |